PALLANTI, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.978
EU - Europa 5.581
AS - Asia 461
AF - Africa 21
Continente sconosciuto - Info sul continente non disponibili 6
SA - Sud America 4
OC - Oceania 2
Totale 13.053
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.955
PL - Polonia 2.791
IT - Italia 739
SE - Svezia 576
IE - Irlanda 571
UA - Ucraina 323
HK - Hong Kong 247
DE - Germania 215
FI - Finlandia 158
GB - Regno Unito 108
CN - Cina 90
VN - Vietnam 44
TR - Turchia 37
FR - Francia 34
JO - Giordania 31
ES - Italia 24
CA - Canada 23
SC - Seychelles 16
NL - Olanda 12
RU - Federazione Russa 10
BE - Belgio 8
CH - Svizzera 8
SG - Singapore 6
A1 - Anonimo 3
BR - Brasile 3
EU - Europa 3
MU - Mauritius 3
JP - Giappone 2
SM - San Marino 2
AU - Australia 1
CL - Cile 1
CY - Cipro 1
DK - Danimarca 1
IN - India 1
IR - Iran 1
KE - Kenya 1
KR - Corea 1
MA - Marocco 1
MT - Malta 1
NZ - Nuova Zelanda 1
Totale 13.053
Salva come PNG Salva come JPEG
Città #
Warsaw 2.790
Fairfield 1.152
Chandler 632
Dublin 568
Jacksonville 545
Woodbridge 540
Ashburn 524
Seattle 490
Cambridge 468
Houston 394
Wilmington 360
Princeton 188
Ann Arbor 161
Florence 125
Boston 117
Altamura 109
Hong Kong 102
Lawrence 90
Boardman 81
San Diego 73
Beijing 72
Buffalo 70
Medford 70
Norwalk 35
Milan 33
Dong Ket 30
Izmir 29
New York 29
Rome 27
Falls Church 24
Andover 19
Barcelona 19
Toronto 19
Frankfurt Am Main 17
Dearborn 14
Phoenix 14
Shanghai 13
Verona 13
Hillsboro 12
Quarrata 11
Redmond 10
London 8
Bern 7
Pisa 7
Prato 7
Brussels 6
Capaccio 6
Laurel 5
San Mateo 5
Auburn Hills 4
Casazza 4
Enterprise 4
Mascalucia 4
Naples 4
Paris 4
Turin 4
Baronissi 3
Bologna 3
Cagliari 3
Campobello di Licata 3
Fuzhou 3
Lanciano 3
Lecce 3
Livorno 3
Loro Ciuffenna 3
Mesagne 3
Messina 3
Moscow 3
Naaldwijk 3
Napoli 3
Perfugas 3
Pontedera 3
Redwood City 3
San Casciano in Val di Pesa 3
Sessa Aurunca 3
Tappahannock 3
Washington 3
Acerra 2
Arnsberg 2
Bari 2
Belmonte Mezzagno 2
Bientina 2
Camogli 2
Castellarano 2
Cecina 2
Cedar Knolls 2
Cento 2
Cohasset 2
Collarmele 2
Crema 2
Düsseldorf 2
Foggia 2
Galveston 2
Groningen 2
Hounslow 2
Impruneta 2
Istanbul 2
Kilburn 2
Latina 2
Leggiuno 2
Totale 10.277
Salva come PNG Salva come JPEG
Nome #
Atomoxetine for hoarding disorder: A pre-clinical and clinical investigation 234
Treatment-refractory obsessive-compulsive disorder: methodological issues, operational definitions and therapeutic lines 225
OBSESSIVE COMPULSIVE DISORDER COMORBIDITY IN DBA 219
RAPID BENEFIT OF INTRAVENOUS PULSE LOADING OF CLOMIPRAMINE IN OBSESSIVE-COMPULSIVE DISORDER. 212
Prevalence and correlates of mental disorders in a school-survey sample. 211
BDNF and ARTEMIN are increased in drug-naïve non-depressed GAD patients: Preliminary data 209
Problematic internet use: is it more compulsory than rewarding or mood driven? 206
Relapse in young paranoid schizophrenic patients: a prospective study of stressful life events, P300 measures, and coping. 205
European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD 202
Separating hope from hype: some ethical implications of the development of deep brain stimulation in psychiatric research and treatment. 200
Phantom Limb Pain: Low Frequency Repetitive Transcranial Magnetic Stimulation in Unaffected Hemisphere 195
Aripiprazole Improves Depressive Symptoms and Immunological Response to Antiretroviral Therapy in an HIV-Infected Subject with Resistant Depression 191
AWARENESS OF ILLNESS AND SUBJECTIVE EXPERIENCE OF COGNITIVE COMPLAINTS IN PATIENTS WITH BIPOLAR I AND BIPOLAR II DISORDER. 189
LITHIUM AND VALPROATE TREATMENT OF PATHOLOGICAL GAMBLING: A RANDOMIZED SINGLE-BLIND STUDY. 187
SHORT REPORT: AUTISTIC GASTROINTESTINAL AND EATING SYMPTOMS TREATED WITH SECRETIN: A SUBTYPE OF AUTISM 187
The Clinical Future of Repetitive Transcranial Magnetic Stimulation and Depression: Separating Hope From Hype 183
RELIABILITY AND VALIDITY OF THE PATHOLOGICAL GAMBLING ADAPTATION OF THE YALE-BROWN OBSESSIVE-COMPULSIVE SCALE (PG-YBOCS) 181
Obsessive–Compulsive Disorder Comorbidity: Clinical Assessment and Therapeutic Implications 180
Resistant social anxiety disorder response to Escitalopram 178
Transcranial magnetic stimulation for the treatment of pharmacoresistant nondelusional auditory verbal hallucinations in dementia 170
The relationship between impulse-control disorders and obsessive–compulsive disorder: A current understanding and future research directions 162
Comprehensive care of schizophrenia: a textbook of clinical management, 2nd edition. 149
Think twice: Impulsivity and decision making in obsessive-compulsive disorder 114
Psichiatria elementare 109
5-HT(1D) function and repetitive behaviors 103
Complex repetitive behavior: Punding after bilateral subthalamic nucleus stimulation in Parkinson's disease 101
Obsessive compulsive and related disorders: Comparing DSM-5 and ICD-11 99
Deep Brain Stimulation of the Anterior Limb of the Internal Capsule May Be Efficacious for Explosive Aggressive Behaviour 97
Abnormal visual event-related potentials in obsessive-compulsive disorder without panic disorder or depression comorbidity 93
New treatment models for compulsive disorders 90
Fronto-thalamo-striatal gray and white matter volumes and anisotropy of their connections in bipolar spectrum illnesses 89
No evidence of linkage between schizophrenia and D2 dopamine receptor gene locus in Italian pedigrees. 89
Enhancing cognitive-behavioral therapy with repetitive transcranial magnetic stimulation in refractory obsessive-compulsive-disorder: A case report 89
Bacopa monnieri as augmentation therapy in the treatment of anhedonia, preclinical and clinical evaluation 89
Excitatory/inhibitory imbalance in autism spectrum disorders: Implications for interventions and therapeutics 88
BASIC SYMPTOMS AND P300 ABNORMALITIES IN YOUNG SCHIZOPHRENIC PATIENTS. 88
Absence of APP713 mutation in Italian and Russian families with schizophrenia. 88
Familiarità, eventi di vita stressanti, stili parentali,temperamento e asse HPA: i possibili determinanti dei disturbi psichiatrici? 87
Basal Ganglia activity in pathological gambling: a fluorodeoxyglucose-positron emission tomography study. 87
Pharmacologic treatment of obsessive-compulsive disorder comorbidity 86
Pharmacological, experimental therapeutic, and transcranial magnetic stimulation treatments for compulsivity and impulsivity 86
CITALOPRAM FOR TREATMENT-RESISTANT OBSESSIVE-COMPULSIVE DISORDER. 85
The Specific Level of Functioning Scale: Construct validity, internal consistency and factor structure in a large Italian sample of people with schizophrenia living in the community 85
Anxiety as a core aspect of schizophrenia 85
Autoimmune markers in vitiligo patients appear correlated with obsession and phobia 84
ICD and DSM: Neuroplasticity and staging are still missing 84
Efficacy of high-frequency (15 Hz) repetitive transcranial magnetic stimulation (rTMS) of the left premotor cortex/dorsolateral prefrontal cortex in decreasing cocaine intake (the MagneTox study): A study protocol for a randomized placebo-controlled pilot trial 83
BRAIN PLASTICITY AND BRAIN STIMULATION IN NEUROPSYCHIATRY:TOWARD INDIVIDUALIZED MEDICINE 83
EPIDEMIOLOGY OF MOOD DISORDERS:A COMMUNITY SURVEY IN FLORENCE 82
NORADRENERGIC FUNCTION IN PATHOLOGICAL GAMBLING:BLUNTED GROWTH HORMONE RESPONSE TO CLONIDINE 82
TRANSCULTURAL OBSERVATIONS OF OBSESSIVE-COMPULSIVE DISORDER 81
Panic attacks with and without agoraphobia: a comparison. 80
OBSESSIVE-COMPULSIVE DISORDER: THEORY, RESEARCH AND TREATMENT 80
EMOTIONAL AROUSAL AND PHOBIA IN TRANSIENT GLOBAL AMNESIA 80
Comorbidity in obsessive-compulsive disorder (OCD): A report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS) 80
Patients’ experience of screening CT colonography with reduced and full bowel preparation in a randomised trial 80
Motor cortex excitability correlates with novelty seeking in social anxiety: a transcranial magnetic stimulation investigation. 80
PULSE LOADING VERSUS GRADUAL DOSING OF INTRAVENOUS CLOMIPRAMINE IN OBSESSIVE-COMPULSIVE DISORDER. 79
Social anxiety in outpatients with schizophrenia: a relevant cause of disability. 79
Streptococcal infections of skin and PANDAS 79
EYE MOVEMENT ABNORMALITIES IN ANOREXIA NERVOSA. 78
The lifetime impact of attention deficit hyperactivity disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) 77
Freud a Firenze. 77
Outcomes with neuromodulation in obsessive- compulsive disorder. 77
PSYCHONEUROIMMUNODERMATOLOGY OF ATOPIC DERMATITIS: FROM EMPIRIC DATA TO THE EVOLUTIONARY HYPOTHESIS 76
Better than treated as usual: Transcranial magnetic stimulation augmentation in selective serotonin reuptake inhibitor-refractory obsessive-compulsive disorder, mini-review and pilot open-label trial 76
MDMA (ECSTASY) PRECIPITATION OF PANIC DISORDER 75
Serotonin function in pathological gambling: blunted growth hormone response to sumatriptan 75
SMOOTH-PURSUIT EYE MOVEMENT AND SACCADIC INTRUSIONS IN OBSESSIVE-COMPULSIVE DISORDER. 74
CITALOPRAM IN ANOREXIA NERVOSA 74
Facial Affect Recognition in CADASIL Patients. 74
SUBJECTIVE EXPERIENCE AND SUBJECTIVE RESPONSE TO NEUROLEPTICS IN SCHIZOPHRENIA. 74
FDG-PET STUDY IN PATHOLOGICAL GAMBLERS 74
PSYCHOSOMATIC FACTORS IN DERMATOLOGY 73
RTMS in resistant mixed states: An exploratory study 73
THE EMERGENCE OF SOCIAL PHOBIA DURING CLOZAPINE TREATMENT AND ITS RESPONSE TO FLUOXETINE AUGMENTATION. 73
PERSONALITY DISORDERS:MYTHS AND NEUROSCIENCE 72
PERCEPTION OF EARLY PARENTING IN PANIC AND AGORAPHOBIA 71
Validity and reliability of the italian version of the quality of life, enjoyment and satisfaction questionnaire 71
KLEPTOMANIA: CLINICAL FEATURES AND COMORBIDITY IN AN ITALIAN SAMPLE. 70
DEPTH PERCEPTION IN SCHIZOPHRENIA 70
An international survey of reported prescribing practice in the treatment of patients with generalised anxiety disorder. 70
A SETTING INCLUDING PSYCHOTHERAPY AND PSYCHOPHARMACOLOGICAL TREATMENT IN A CASE OF ANOREXIA NERVOSA WITH OBSESSIVE-COMPULSIVE DISORDER COMORBIDITY 69
Major depression and bipolar disorders in CADASIL: a study using the DSM-IV semi-structured interview 69
EFFECTS OF CLOZAPINE ON AWARENESS OF ILLNESS AND COGNITION IN SCHIZOPHRENIA. 69
A double-blind, placebo-controlled trial of topiramate for pathological gambling 69
Cigarette smoking in patients with obsessive compulsive disorder: A report from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS) 69
SUCCESSFUL DULOXETINE TREATMENT OF A BINGE-EATING DISORDER:A CASE REPORT. 68
[Validity and reliability of Quality of Life, Enjoyment and Satisfaction Questionnaire, Short Form]. 68
SUSTAINED RESPONSE VERSUS RELAPSE: THE PHARMACOTHERAPEUTIC GOAL FOR OBSESSIVE-COMPULSIVE DISORDER 66
INTRAVENOUS CLOMIPRAMINE CHALLENGE IN OBSESSIVE-COMPULSIVE DISORDER: PREDICTING RESPONSE TO ORAL THERAPY AT EIGHT WEEKS 66
PHARMACOLOGICAL TREATMENTS OF PATHOLOGICAL GAMBLING 66
Bipolar disorder and comorbid attention deficit hyperactivity disorder.A distinct clinical phenotype?Clinical characteristics and temperamental traits. 65
Emerging drugs to treat obsessive-compulsive disorder 65
FDA considers classification of ECT. 64
DEPRESSIVE RELAPSES AND INCOMPLETE RECOVERY FROM INDEX EPISODE 63
ATTACHMENT PROCESS IN EATING DISORDERS 62
Low-frequency rTMS over right dorsolateral prefrontal cortex in the treatment of resistant depression: cognitive improvement is independent from clinical response, resting motor threshold is related to clinical response. 62
Unilateral low frequency versus sequential bilateral repetitive transcranial magnetic stimulation: is simpler better for treatment of resistant depression? 62
RISPERIDONE AUGMENTATION IN TREATMENT-RESISTANT OBSESSIVE-COMPULSIVE DISORDER: A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY. 61
Totale 10.405
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.344
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.344
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.170 0 0 0 0 0 0 0 0 0 245 509 416
2019/20203.157 254 283 98 295 345 384 314 411 287 168 277 41
2020/20212.078 198 160 180 185 90 281 75 182 166 296 101 164
2021/20221.009 39 88 66 45 49 48 29 63 54 56 172 300
2022/20232.498 336 296 77 208 211 492 312 164 235 45 91 31
2023/2024812 48 117 192 59 54 92 77 147 11 15 0 0
Totale 13.115